Thrombospondin 1 as an enzyme inhibitor.
Hogg
P J
PJ
Centre for Thrombosis and Vascular Research, School of Pathology, University of New South Wales, Sydney, Australia.
D000595:Amino Acid Sequence; D000818:Animals; D056649:Cathepsin G; D002403:Cathepsins / Q000037:antagonists & inhibitors; D004791:Enzyme Inhibitors / Q000097:blood*; D005341:Fibrinolysin / Q000037:antagonists & inhibitors; D006801:Humans; D019272:Leukocyte Elastase; D008562:Membrane Glycoproteins / Q000502:physiology*; D008969:Molecular Sequence Data; D009504:Neutrophils / Q000201:enzymology*; D010196:Pancreatic Elastase / Q000037:antagonists & inhibitors; D012697:Serine Endopeptidases; D019699:Thrombospondins; D014568:Urokinase-Type Plasminogen Activator / Q000037:antagonists & inhibitors
D004791:Enzyme Inhibitors; D008562:Membrane Glycoproteins; D019699:Thrombospondins; D002403:Cathepsins; D012697:Serine Endopeptidases; C534094:CTSG protein, human; D056649:Cathepsin G; D010196:Pancreatic Elastase; D019272:Leukocyte Elastase; D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator